Intuitive Surgical Inc. (0R29)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 447.20 |
|---|---|
| 52-week range | 328.37 – 603.32 |
| Return, 1 month / 3 months | +10.8% / +25.1% |
| Return, 1 year / 3 years | −18.5% / +72.7% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 33.6% |
| Worst drawdown (1 year) | -44.2% |
| Average daily value traded | 1.15M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Intuitive Surgical makes robotic systems for minimally invasive surgery, most notably the da Vinci platform, which surgeons use to operate through small incisions with enhanced vision and precision. The company also provides the instruments, accessories and support services that hospitals need to use its systems. Its customers are hospitals and surgical teams around the world. Intuitive Surgical is based in Sunnyvale, California, in the United States.
Intuitive Surgical Inc. trades under the code 0R29 on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Intuitive Surgical Inc. (0R29) trades on the London Stock Exchange in UK. It last closed at USD 447.20 on 27 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,377 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.5% and over the last three months it rose 25.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 3.1% | ||
| From 52-week high | -24.7% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 25.1% | ||
| 6-month return | -5.4% | ||
| 12-month return, skipping the last month | -26.5% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.2% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.15M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | +10.8% |
| 3 months | +25.1% |
| 6 months | −5.4% |
| 1 year | −18.5% |
| 3 years | +72.7% |
| 5 years | +27.7% |
Signals
| 50-day / 200-day average | 398.46 / 433.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.00 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.